Abstract:Abstract BACKGROUND Surgery activates catabolic pathways that lead to loss of lean body mass and physical deconditioning, which can predispose to complications and delayed healing. Prehabilitation addresses modifiable risk factors, provides nutrition and functional status optimization, and has been shown to optimize surgical outcomes after cancer and/or orthopedic surgery. This includes decreased hospital length of stay (LOS), postoperative complications, readmission rates, and accelerated return to pre-surgical functional capacity. We assessed the feasibility of a structured, multidisciplinary prehabilitation program for patients with inflammatory bowel disease (IBD) undergoing abdominal surgery. METHODS We developed a nurse-practitioner and dietitian-led IBD prehabilitation program for patients undergoing ileal-cecal resection (ICR) or colectomy. Perioperative nutrition and medications were addressed during two clinic visits (4 weeks before and after surgery). The Global Leadership Initiative on Malnutrition (GLIM) criteria were used to define malnutrition. Sarcopenia was defined as either (1) two standard deviations below the norm for age and gender as assessed by dynamometry or (2) skeletal muscle index (SMI) <55 cm2/m2 for males and <39 cm2/m2 for females at the L3 region as assessed by computerized tomography. Micronutrients (iron profile, vitamin D, B6, zinc) were assessed and corrected if a deficiency was found. Patients were provided personalized diet recommendations for optimizing nutrition and were counseled on preoperative carbohydrate loading, and pre- and post-operative immunonutrition (IN). We assessed post-operative outcomes including post-operative length-of-stay (LOS), 30-day readmission, and perioperative complications of infection, abscess, and leak. RESULTS Ten patients (70% female, mean age 41 years) completed the program between 3/2021 and 5/2022. 9 underwent ICR and 1 underwent colectomy. 9 completed IN pre-operatively (90%); 9 (90%) completed carbohydrate loading pre-operatively, and 4 (40%) completed IN post-operatively. Upon initial assessment, 6 patients (60%) had malnutrition, and among the 4 patients with sarcopenia assessments, all 4 met criteria for sarcopenia. Forty percent had at least one micronutrient deficiency. Median post-operative LOS was 3.5 days. There were no readmissions within 30 days, and one patient had a postoperative infection. CONCLUSION A nurse practitioner- and dietician-led structured prehabilitation program is feasible. We hypothesize that low compliance with post-operative IN was due to formula not being available for inpatients at our facility; the impact of IN on post-operative outcomes should be evaluated in future studies. Further evaluation of outcomes associated with structured, multidisciplinary prehabilitation in IBD relative to usual care is warranted.

The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial)

Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre, Open-Label, Randomised Trial (INu-RC)

Nutritional Prehabilitation in Patients Undergoing Cystectomy: A Systematic Review

Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study

Randomized Controlled Trial Investigating Perioperative Immunonutrition for Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Impact of Immunonutrition on Nutritional Status in Patients Undergoing Colorectal Cancer Surgery: A Randomized Controlled Clinical Trial

Immunonutrition in ovarian cancer: clinical and immunological impact?

Pre-Operative Immunonutrition Enhances Postoperative Outcomes and Elevates Tumor-Infiltrating Lymphocyte Counts in Colorectal Cancer Patients: A Meta-Analysis of Randomized Controlled Trials

Effects of immune-enhancing nutrition on radical cystectomy outcomes: Primary results from the randomized phase III double-blind clinical trial (S1600).

Efficacy of perioperative immunonutrition in visceral surgery: an umbrella review protocol

Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications

Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery

The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design

Immunonutrition in patients undergoing major upper gastrointestinal surgery: a prospective double-blind randomised controlled study

Effect of immunonutrition on colorectal cancer patients undergoing surgery: a meta-analysis

Effects of oral immunonutritional supplement on 3-year disease-free survival in gastric cancer patients with pathological stage III after total gastrectomy (CRUCIAL): study protocol of a multicentre, randomised clinical trial

FEASIBILITY OF A NURSE AND DIETITIAN-LED IBD SURGICAL PREHABILITATION PROGRAM

Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

Preoperative Enteral Immunonutrition Improves Postoperative Outcome in Patients with Gastrointestinal Cancer

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma

Systemic Inflammatory Index : A promising non-invasive marker for the prediction of response to neoadjuvant chemotherapy prior to cystectomy.